The Lancet Haematology

Personalised multipeptide-based T-cell activator for chronic lymphocytic leukaemia: an open-label, single-centre, phase 1 study.

Pub Date : 2026-01-14 DOI: 10.1016/s2352-3026(25)00323-0 Jonas S Heitmann,Yacine Maringer,Susanne Jung,Marcel Wacker,Christopher Hackenbruch,Mark Polster,Maddalena Marconato,Annika Nelde,Jens Bauer,Melissa Zwick,Anna-Sophia Baur,Ariane Lehmann,Christopher Krolla,Geoffroy Andrieux,Natalie Köhler,Melanie Boerries,Monika Denk,Lisa Zieschang,Christine Kammer,Naomi Hoenisch-Gravel,Marion Richter,Melek Tutku Oezbek,Stefan Wirths,Anna Dengler,Marissa L Dubbelaar,Marina Pumptow,Peter Martus,Monika Brüggemann,Hans-Georg Rammensee,Helmut R Salih,Juliane S Walz

2025 ASH Annual Meeting

Pub Date : 2025-12-22 DOI: 10.1016/s2352-3026(25)00360-6 Daniela Marín

Sequencing T-cell therapy for relapsed or refractory large B-cell lymphoma

Pub Date : 2025-12-22 DOI: 10.1016/s2352-3026(25)00342-4 Reem Karmali, Leo I Gordon